Tag: Michael Parenti

02/01/2019

Guest Commentary: What Might a Part B IPI Model Do to Drug Innovation, Patient Care?

CHC_FDA-Regulatory Images2

06/26/2018

Guest Commentary: Exploring a New Frontier in Healthcare